Skip to main content
. 2012 Sep 3;4(5):790–794. doi: 10.3892/etm.2012.694

Table VII.

KRAS analysis of plasma preoperatively and 6 months postoperatively.

Plasma KRAS mutation site
Patient Gender Age Preoperatively Postoperatively
1 Female 71 Gly13Asp Wild-type
2 Female 81 Gly12Val Wild-type
4 Male 72 Gly12Ser Wild-type
5 Female 51 Gly13Asp Wild-type
6 Female 78 Gly12Val Wild-type